to acquire Tokyo-based chip materials maker JSR Corp. for around 1 trillion yen ($7 billion) in a strategic shift to shore up the domestic semiconductor industry. JSR holds a 26 percent share in ...
JSR, which focuses on semiconductor materials and medical business, reported a net profit of 15.7 billion yen on sales of 409 billion yen for the business year that ended in March.
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, has been honored with the 2024 ...